These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 27855531)
1. ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib. Wei D; Zhang H; Peng R; Huang C; Bai R Xenobiotica; 2017 Nov; 47(11):1008-1014. PubMed ID: 27855531 [TBL] [Abstract][Full Text] [Related]
2. In vitro Transport Ability of Lian G; Yuan J; Gao Y Onco Targets Ther; 2020; 13():1413-1419. PubMed ID: 32110040 [TBL] [Abstract][Full Text] [Related]
3. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Kim WJ; Lee JH; Yi J; Cho YJ; Heo K; Lee SH; Kim SW; Kim MK; Kim KH; In Lee B; Lee MG Pharmacogenet Genomics; 2010 Apr; 20(4):249-56. PubMed ID: 20216337 [TBL] [Abstract][Full Text] [Related]
4. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol. Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920 [TBL] [Abstract][Full Text] [Related]
5. Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice. Edginton AN; Zimmerman EI; Vasilyeva A; Baker SD; Panetta JC Cancer Chemother Pharmacol; 2016 May; 77(5):1039-52. PubMed ID: 27053087 [TBL] [Abstract][Full Text] [Related]
6. Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition. Elens L; Tyteca D; Panin N; Courtoy P; Lison D; Demoulin JB; Haufroid V Pharmacogenet Genomics; 2011 Dec; 21(12):884-93. PubMed ID: 22027652 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants. Wen X; Joy MS; Aleksunes LM Pharm Res; 2017 Aug; 34(8):1637-1647. PubMed ID: 28405913 [TBL] [Abstract][Full Text] [Related]
8. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy. Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles. Lai Y; Xing L; Poda GI; Hu Y Drug Metab Dispos; 2007 Jun; 35(6):937-45. PubMed ID: 17371800 [TBL] [Abstract][Full Text] [Related]
10. Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. Laechelt S; Turrini E; Ruehmkorf A; Siegmund W; Cascorbi I; Haenisch S Pharmacogenomics J; 2011 Feb; 11(1):25-34. PubMed ID: 20351751 [TBL] [Abstract][Full Text] [Related]
11. MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma. Tomonari T; Takeishi S; Taniguchi T; Tanaka T; Tanaka H; Fujimoto S; Kimura T; Okamoto K; Miyamoto H; Muguruma N; Takayama T Oncotarget; 2016 Feb; 7(6):7207-15. PubMed ID: 26769852 [TBL] [Abstract][Full Text] [Related]
12. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379. Werk AN; Bruckmueller H; Haenisch S; Cascorbi I Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544 [TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms of ABCC2 modulate renal secretion of endogenous organic anions. Muhrez K; Largeau B; Emond P; Montigny F; Halimi JM; Trouillas P; Barin-Le Guellec C Biochem Pharmacol; 2017 Sep; 140():124-138. PubMed ID: 28532626 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b. Vasilyeva A; Durmus S; Li L; Wagenaar E; Hu S; Gibson AA; Panetta JC; Mani S; Sparreboom A; Baker SD; Schinkel AH Cancer Res; 2015 Jul; 75(13):2729-36. PubMed ID: 25952649 [TBL] [Abstract][Full Text] [Related]
15. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565 [TBL] [Abstract][Full Text] [Related]
16. ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects. Cao K; Ren G; Lu C; Wang Y; Tan Y; Zhou J; Zhang Y; Lu Y; Li N; Chen X; Zhao D Eur J Clin Pharmacol; 2020 Jan; 76(1):51-59. PubMed ID: 31677118 [TBL] [Abstract][Full Text] [Related]
17. Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China. Zhao T; Li HJ; Zhang HL; Feng J; Yu J; Wang TT; Sun Y; Yu LH Ther Drug Monit; 2023 Feb; 45(1):117-125. PubMed ID: 36253887 [TBL] [Abstract][Full Text] [Related]
18. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2). Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270 [TBL] [Abstract][Full Text] [Related]
19. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis. Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]